Purchases and Sales Made in Q1 2022 in Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY) during Q1 2022. The information is specifically focused on institutions that hold shares of Unicycive Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Apr 22, 2022
Q1 2022
|
Truist Financial Corp
|
BUY
|
- |
37.5KNew |
$40.1K - $85.4K
|
37.5K
$30.3K
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
8.12K+ 50.61% |
$8.69K - $18.5K
|
24.2K
$19.6K
|
|
May 12, 2022
Q1 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.84KNew |
$4.11K - $8.76K
|
3.84K
$3.11K
|
|
May 16, 2022
Q1 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 3.13% |
$1.07 - $2.28
|
33
$26.7
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2Closed |
$2.14 - $4.56
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-21Closed |
$22.5 - $47.9
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
SELL
|
- |
-5.27KClosed |
$5.64K - $12K
|
0
$0
|
|
May 13, 2022
Q1 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-46.1K- 6.72% |
$49.4K - $105K
|
641K
$519K
|